Patient Guide: A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 157 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06943872
Status: 🟢 Enrolling Now
Condition: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase: PHASE3

Where You Can Participate

This study is available at 157 locations across the country.

Top locations include:
  • • Orange, California
  • • Palo Alto, California
  • • San Diego, California
  • • And 154 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) - Join Clinical Trial NCTNCT06943872

How to Join This Clinical Trial - NCTNCT06943872

Learn how to participate in this PHASE3 trial studying an investigational therapy for Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06943872 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 157 locations. Find a study site near you:

Clinical Research Site

Orange, California 92868-3201 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Palo Alto, California 94304-2205 - United States

Status: RECRUITING

Clinical Research Site

San Diego, California 92103-2106 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Aurora, Colorado 80012-5405 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

New Haven, Connecticut 06520-8028 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Norwich, Connecticut 06360-2700 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Weston, Florida 33331-3609 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Chicago, Illinois 60611 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Niles, Illinois 60714-5905 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Waukee, Iowa 50263 - United States

Status: NOT_YET_RECRUITING

And 147 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships